LAMDA PHARMA LIMITED

Company number 09421468

Date	Type	Description	View / Download
13 Jul 2024	RP04AP01	Second filing for the appointment of Mr Jerome Marie Joseph Charton as a director	(3 pages)
16 May 2024	AP03	Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024	(2 pages)
16 May 2024	AP01	Appointment of Mr Jerome Marie Joseph Charton as a director on 30 April 2024 ANNOTATION Clarification a second filed AP01 was registered on 13/07/24	(3 pages)
07 Apr 2024	AA	Audit exemption subsidiary accounts made up to 30 June 2023	(15 pages)
07 Apr 2024	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 30/06/23	(65 pages)
07 Apr 2024	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 30/06/23	(3 pages)
07 Apr 2024	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 30/06/23	(1 page)
16 Feb 2024	CS01	Confirmation statement made on 4 February 2024 with no updates	(3 pages)
23 Nov 2023	TM01	Termination of appointment of Samuel Gordon Herbert as a director on 13 October 2023	(1 page)
05 May 2023	AA	Audit exemption subsidiary accounts made up to 30 June 2022	(15 pages)
05 May 2023	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 30/06/22	(71 pages)
05 May 2023	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 30/06/22	(1 page)
05 May 2023	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 30/06/22	(3 pages)
06 Mar 2023	AP01	Appointment of Mr Samuel Gordon Herbert as a director on 6 March 2023	(2 pages)
22 Feb 2023	TM01	Termination of appointment of Xanthippos Xanthakis as a director on 22 February 2023	(1 page)
22 Feb 2023	TM01	Termination of appointment of Angelos Karatzas as a director on 22 February 2023	(1 page)
22 Feb 2023	TM01	Termination of appointment of Ipatia Efraimidou as a director on 22 February 2023	(1 page)
21 Feb 2023	CS01	Confirmation statement made on 4 February 2023 with no updates	(3 pages)
21 Feb 2023	CH01	Director's details changed for Ipatia Efraimidou on 24 June 2021	(2 pages)
21 Feb 2023	PSC05	Change of details for Quantum Pharma Group Limited as a person with significant control on 24 June 2021	(2 pages)
31 Jan 2023	TM02	Termination of appointment of Amanda Miller as a secretary on 16 January 2023	(1 page)
01 Apr 2022	AA	Audit exemption subsidiary accounts made up to 30 June 2021	(15 pages)
01 Apr 2022	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 30/06/21	(146 pages)
01 Apr 2022	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 30/06/21	(3 pages)
01 Apr 2022	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 30/06/21	(1 page)